Literature DB >> 5096846

A study of encounter group casualties.

I D Yalom, M A Lieberman.   

Abstract

Mesh：

Year:  1971        PMID： 5096846     DOI： 10.1001/archpsyc.1971.01750130018002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  7 in total

1.  A critique of some current approaches to the problem of drug abuse.

Authors:  D B Louria
Journal:  Am J Public Health       Date:  1975-06       Impact factor: 9.308

2.  Effeminacy. II. Variation with social context.

Authors:  M P Westfall; A F Schatzberg; A B Blumetti; C L Birk
Journal:  Arch Sex Behav       Date:  1975-01

3.  Encounter groups.

Authors:  J S Peck
Journal:  Calif Med       Date:  1972-07

4.  Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED).

Authors:  Nicole E Caporino; Dara Sakolsky; Douglas M Brodman; Joseph F McGuire; John Piacentini; Tara S Peris; Golda S Ginsburg; John T Walkup; Satish Iyengar; Philip C Kendall; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-06-06       Impact factor: 8.829

5.  [Undesired treatment effects in behavior group therapy: Frequency and spectrum].

Authors:  M Linden; M Walter; K Fritz; B Muschalla
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

Review 6.  Adverse outcomes in group psychotherapy: risk factors, prevention, and research directions.

Authors:  H B Roback
Journal:  J Psychother Pract Res       Date:  2000

7.  Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.

Authors:  Nicole E Caporino; Douglas M Brodman; Philip C Kendall; Anne Marie Albano; Joel Sherrill; John Piacentini; Dara Sakolsky; Boris Birmaher; Scott N Compton; Golda Ginsburg; Moira Rynn; James McCracken; Elizabeth Gosch; Courtney Keeton; John March; John T Walkup
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-11-30       Impact factor: 8.829
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.